Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making?

Blood. 1999 May 1;93(9):2755-9.
No abstract available

Publication types

  • Review

MeSH terms

  • Fusion Proteins, bcr-abl / genetics*
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Neoplasm, Residual
  • Polymerase Chain Reaction / methods*

Substances

  • Fusion Proteins, bcr-abl